CGS 15855A: dopamine receptor D2 agonist; structure given in first source; RN given refers to (trans(+-))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 14450365 |
| SCHEMBL ID | 9840872 |
| MeSH ID | M0146174 |
| Synonym |
|---|
| isomolpan hydrochloride |
| cgs 15855a |
| rek7i52i58 , |
| (+-)-trans-1,3,4,4a5,10b-hexahydro-4-propyl-2h (1)benzopyrano(3,4-b)pyridin-9-ol hydrochloride |
| isomolpan hcl |
| unii-rek7i52i58 |
| isomolpan hydrochloride [usan] |
| 2h-(1)benzopyrano(3,4-b)pyridin-9-ol, 1,3,4,4a,5,10b-hexahydro-4-propyl-, hydrochloride, trans |
| (+/-)-trans-1,3,4,4a,5,10b-hexahydro-4-propyl-2h-(1)benzopyrano(3,4-b)pyridin-9-ol hydrochloride |
| isomolpan hydrochloride [who-dd] |
| SCHEMBL9840872 |
| Q27288077 |
| (4as,10br)-4-propyl-1,2,3,4a,5,10b-hexahydrochromeno[3,4-b]pyridin-9-ol;hydrochloride |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||